Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats
The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 an...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental hypertension (1993) 1991, Vol.A13 (2), p.219-234 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 234 |
---|---|
container_issue | 2 |
container_start_page | 219 |
container_title | Clinical and experimental hypertension (1993) |
container_volume | A13 |
creator | Secrest, Roberta J. Williams, Patricia Bonjouklian, Rosanne Modlin, Deah Firman, Kenneth Turk, John Cohen, Marlene L. |
description | The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone. |
doi_str_mv | 10.3109/10641969109042060 |
format | Article |
fullrecord | <record><control><sourceid>informahealthcare_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_19840342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_10641969109042060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</originalsourceid><addsrcrecordid>eNp9UMtKxDAUDaL4_gAXQjburCZtGht0I-ILRcXRdbmT3jKRTlKSjDJ-vdEZFRFmdQ_3PHJzCNnh7KDgTB1yJgVXUiXMRM4kWyLrvMzLTDImlxNOfJYExRrZCOGFMS5kWa2S1aQtE1wn71fT3kW0wbwiffCuRx8NBupaGkdfm4jG0htjISC9tiMzNNH5fTqIMPEu9M4bi_s0ae6cH_9EgW3ooHc2gkU3Cd2UpodS9px-hBi2yEoLXcDt-dwkzxfnT2dX2e395fXZ6W2mhWQxa4FXoJu8alDpSkloiqHIVamRKcUV8FKXR0JLgcC1aIaq1byEthBcaJ0jKzYJn-XqdG_w2Na9N2Pw05qz-rPG-l-NybM78_ST4RibH8e8t8TvzXkIGrrWg9Um_AarSrBC5El3MtMZ26Z64M35rqkjTDvnv03FojOO_9hHCF0cafBYv7iJt6m2BZ_4AANQorA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</title><source>MEDLINE</source><source>Taylor & Francis Journals Complete</source><creator>Secrest, Roberta J. ; Williams, Patricia ; Bonjouklian, Rosanne ; Modlin, Deah ; Firman, Kenneth ; Turk, John ; Cohen, Marlene L.</creator><creatorcontrib>Secrest, Roberta J. ; Williams, Patricia ; Bonjouklian, Rosanne ; Modlin, Deah ; Firman, Kenneth ; Turk, John ; Cohen, Marlene L.</creatorcontrib><description>The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.</description><identifier>ISSN: 1064-1963</identifier><identifier>ISSN: 0730-0077</identifier><identifier>EISSN: 1525-6006</identifier><identifier>DOI: 10.3109/10641969109042060</identifier><identifier>PMID: 2065465</identifier><identifier>CODEN: CEHADM</identifier><language>eng</language><publisher>Basel: Informa UK Ltd</publisher><subject>Alkaloids - pharmacology ; Animals ; Aorta ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure ; Blood Pressure - drug effects ; Cardiology. Vascular system ; Decerebrate State ; Experimental diseases ; Heart Rate ; Heart Rate - drug effects ; Hemodynamics - drug effects ; Hypotension - chemically induced ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; Protein Kinase Inhibitors ; Rat ; Rats ; Rats, Inbred SHR - physiology ; Rats, Inbred Strains ; Reference Values ; Serotonin - pharmacology ; Staurosporine ; Vasoconstriction - drug effects</subject><ispartof>Clinical and experimental hypertension (1993), 1991, Vol.A13 (2), p.219-234</ispartof><rights>1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1991</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</citedby><cites>FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/10641969109042060$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/10641969109042060$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,4009,27902,27903,27904,59624,60413,61198,61379</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19840342$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2065465$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Secrest, Roberta J.</creatorcontrib><creatorcontrib>Williams, Patricia</creatorcontrib><creatorcontrib>Bonjouklian, Rosanne</creatorcontrib><creatorcontrib>Modlin, Deah</creatorcontrib><creatorcontrib>Firman, Kenneth</creatorcontrib><creatorcontrib>Turk, John</creatorcontrib><creatorcontrib>Cohen, Marlene L.</creatorcontrib><title>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</title><title>Clinical and experimental hypertension (1993)</title><addtitle>Clin Exp Hypertens A</addtitle><description>The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.</description><subject>Alkaloids - pharmacology</subject><subject>Animals</subject><subject>Aorta</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiology. Vascular system</subject><subject>Decerebrate State</subject><subject>Experimental diseases</subject><subject>Heart Rate</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>Hypotension - chemically induced</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Protein Kinase Inhibitors</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Inbred SHR - physiology</subject><subject>Rats, Inbred Strains</subject><subject>Reference Values</subject><subject>Serotonin - pharmacology</subject><subject>Staurosporine</subject><subject>Vasoconstriction - drug effects</subject><issn>1064-1963</issn><issn>0730-0077</issn><issn>1525-6006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UMtKxDAUDaL4_gAXQjburCZtGht0I-ILRcXRdbmT3jKRTlKSjDJ-vdEZFRFmdQ_3PHJzCNnh7KDgTB1yJgVXUiXMRM4kWyLrvMzLTDImlxNOfJYExRrZCOGFMS5kWa2S1aQtE1wn71fT3kW0wbwiffCuRx8NBupaGkdfm4jG0htjISC9tiMzNNH5fTqIMPEu9M4bi_s0ae6cH_9EgW3ooHc2gkU3Cd2UpodS9px-hBi2yEoLXcDt-dwkzxfnT2dX2e395fXZ6W2mhWQxa4FXoJu8alDpSkloiqHIVamRKcUV8FKXR0JLgcC1aIaq1byEthBcaJ0jKzYJn-XqdG_w2Na9N2Pw05qz-rPG-l-NybM78_ST4RibH8e8t8TvzXkIGrrWg9Um_AarSrBC5El3MtMZ26Z64M35rqkjTDvnv03FojOO_9hHCF0cafBYv7iJt6m2BZ_4AANQorA</recordid><startdate>1991</startdate><enddate>1991</enddate><creator>Secrest, Roberta J.</creator><creator>Williams, Patricia</creator><creator>Bonjouklian, Rosanne</creator><creator>Modlin, Deah</creator><creator>Firman, Kenneth</creator><creator>Turk, John</creator><creator>Cohen, Marlene L.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Dekker</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1991</creationdate><title>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</title><author>Secrest, Roberta J. ; Williams, Patricia ; Bonjouklian, Rosanne ; Modlin, Deah ; Firman, Kenneth ; Turk, John ; Cohen, Marlene L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Alkaloids - pharmacology</topic><topic>Animals</topic><topic>Aorta</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiology. Vascular system</topic><topic>Decerebrate State</topic><topic>Experimental diseases</topic><topic>Heart Rate</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>Hypotension - chemically induced</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Protein Kinase Inhibitors</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Inbred SHR - physiology</topic><topic>Rats, Inbred Strains</topic><topic>Reference Values</topic><topic>Serotonin - pharmacology</topic><topic>Staurosporine</topic><topic>Vasoconstriction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Secrest, Roberta J.</creatorcontrib><creatorcontrib>Williams, Patricia</creatorcontrib><creatorcontrib>Bonjouklian, Rosanne</creatorcontrib><creatorcontrib>Modlin, Deah</creatorcontrib><creatorcontrib>Firman, Kenneth</creatorcontrib><creatorcontrib>Turk, John</creatorcontrib><creatorcontrib>Cohen, Marlene L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical and experimental hypertension (1993)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Secrest, Roberta J.</au><au>Williams, Patricia</au><au>Bonjouklian, Rosanne</au><au>Modlin, Deah</au><au>Firman, Kenneth</au><au>Turk, John</au><au>Cohen, Marlene L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</atitle><jtitle>Clinical and experimental hypertension (1993)</jtitle><addtitle>Clin Exp Hypertens A</addtitle><date>1991</date><risdate>1991</risdate><volume>A13</volume><issue>2</issue><spage>219</spage><epage>234</epage><pages>219-234</pages><issn>1064-1963</issn><issn>0730-0077</issn><eissn>1525-6006</eissn><coden>CEHADM</coden><abstract>The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.</abstract><cop>Basel</cop><cop>Hong Kong</cop><cop>New York, NY</cop><pub>Informa UK Ltd</pub><pmid>2065465</pmid><doi>10.3109/10641969109042060</doi><tpages>16</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1064-1963 |
ispartof | Clinical and experimental hypertension (1993), 1991, Vol.A13 (2), p.219-234 |
issn | 1064-1963 0730-0077 1525-6006 |
language | eng |
recordid | cdi_pascalfrancis_primary_19840342 |
source | MEDLINE; Taylor & Francis Journals Complete |
subjects | Alkaloids - pharmacology Animals Aorta Arterial hypertension. Arterial hypotension Biological and medical sciences Blood and lymphatic vessels Blood Pressure Blood Pressure - drug effects Cardiology. Vascular system Decerebrate State Experimental diseases Heart Rate Heart Rate - drug effects Hemodynamics - drug effects Hypotension - chemically induced Medical sciences Muscle, Smooth, Vascular - drug effects Protein Kinase Inhibitors Rat Rats Rats, Inbred SHR - physiology Rats, Inbred Strains Reference Values Serotonin - pharmacology Staurosporine Vasoconstriction - drug effects |
title | Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T07%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypotensive%20Properties%20of%20the%20Protein%20Kinase%20Inhibitor,%20Staurosporine,%20in%20Normotensive%20and%20Spontaneously%20Hypertensive%20Rats&rft.jtitle=Clinical%20and%20experimental%20hypertension%20(1993)&rft.au=Secrest,%20Roberta%20J.&rft.date=1991&rft.volume=A13&rft.issue=2&rft.spage=219&rft.epage=234&rft.pages=219-234&rft.issn=1064-1963&rft.eissn=1525-6006&rft.coden=CEHADM&rft_id=info:doi/10.3109/10641969109042060&rft_dat=%3Cinformahealthcare_pasca%3E10_3109_10641969109042060%3C/informahealthcare_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2065465&rfr_iscdi=true |